CVS Health announced this week that it is doubling its COVID-19 drive-thru testing sites, giving it more than 4,000 nationwide — and detailing 400 new sites, including 21 in New Jersey.
The Rhode Island-based drugstore giant said in a news release that it will add more than 2,000 new testing sites to help increase access to testing and slow the spread of the coronavirus pandemic.
CVS said it currently manages the largest number of independently run COVID-19 test sites in the U.S. It hopes to have the new sites open in waves through mid-October, building on its availability in 33 states and the District of Columbia.
Some 400 sites are opening Friday, CVS said, including 21 in New Jersey:
- 25 Pemberton Brown Mills Road, Browns Mills;
- 80 Piermont Road, Cresskill;
- 1795 Hooper Ave., Dover;
- 350 Rt. 130, East Windsor;
- 6103 W. Jersey Ave., Egg Harbor Township;
- 1320 Parkway Ave., Ewing Township;
- 18-35 River Road, Fair Lawn;
- 3211 Route 27, Franklin Park;
- 2 Don Connor Blvd., Jackson;
- 238 Forsgate Drive, Jamesburg;
- 220 Schuyler Ave., Kearny;
- 780 Rt. 22 E., North Plainfield;
- 700 Broad St., Riverton;
- 1600 Rt. 35, Seaside Heights;
- 2006 Rt. 322, Swedesboro;
- 1497 Rt. 206, Tabernacle;
- 1100 Liberty St., Trenton;
- 1501 Bayshore Road, Villas;
- 1000 Kresson Road, Voorhees;
- 452 Rt. 9, Waretown;
- 1 Levitt Parkway, Willingboro.
The new sites will give CVS a total of 78 COVID-19 test sites in the Garden State.
“Since opening our first test site in March, we’ve been able to quickly adapt to the changing landscape in order to make it easier for people in the communities we serve to access testing,” Chief Operating Officer Jon Roberts, also the acting president of CVS Pharmacy, said in a prepared statement. “We recognize the critical role testing plays in helping to manage the spread of the virus, and are incredibly proud of how our teams have responded to this need while continuing to take care of our customers, clients and patients.”